Related Experiment Video
Updated: Oct 9, 2025

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy
Mahshid Deldar Abad Paskeh1, Maliheh Entezari1, Courtney Clark2
1Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Abstract:
Normal cells depend on autophagy to maintain cellular homeostasis by recycling damaged organelles and misfolded proteins and degrading toxic agents. Similar to apoptosis, targeting autophagy has been under attention in cancer therapy. However, autophagy has both pro-survival and pro-death functions in tumors, and its targeting requires further elucidation. The current review focuses on using nanoparticles for targeting autophagy in cancer treatment. Nanocarriers can deliver autophagy regulators along with chemotherapeutic agents leading to intracellular accumulation in cancer cells and synergistic cancer therapy. Furthermore, genetic tools such as siRNA and shRNA can be used for targeting molecular components that regulate autophagy, such as the ATG12-ATG5-ATG16L1 complex. A number of nanostructures, such as gold and zinc oxide nanoparticles, can be used to enhance oxidative stress-mediated apoptosis and autophagy, reducing cancer progression. Further, using nanoparticles to modulate autophagy potentiates the anti-tumor effects of cisplatin and gefitinib during chemotherapy. Polymeric nanoparticles, lipid-based nanostructures and carbon-based nanomaterials are among other nanoparticles capable of regulating autophagy in cancer cells. Of note, various regulatory components of autophagy such as ATGs, Beclin-1 and LC3-II can be affected by nanomaterials. Based on the role of nanomaterial-induced autophagy as pro-survival or pro-death, further targeting can potentiate the fight against cancer cells.
Insights
Nanoparticles offer a promising strategy for cancer therapy by targeting autophagy, a cellular process involved in homeostasis and tumor progression. Modulating autophagy with nanoparticles can enhance chemotherapy effectiveness and reduce cancer growth.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Cell Biology
Background:
- Autophagy is crucial for cellular homeostasis, involving the recycling of damaged components and degradation of toxic substances.
- Targeting autophagy is a growing area in cancer therapy due to its dual role in promoting or inhibiting tumor progression.
- Understanding the complex functions of autophagy in tumors is essential for effective therapeutic strategies.
Purpose of the Study:
- To review the application of nanoparticles in targeting autophagy for cancer treatment.
- To explore how nanocarriers can deliver autophagy regulators and chemotherapeutics for synergistic effects.
- To discuss the potential of nanomaterials in modulating autophagy-induced apoptosis and enhancing anti-cancer therapies.
Main Methods:
- Review of current literature on nanoparticle-mediated autophagy targeting in cancer.
- Analysis of nanocarrier systems for delivering autophagy regulators and chemotherapeutic agents.
- Investigation of specific nanomaterials (e.g., gold, zinc oxide, polymeric, lipid-based, carbon-based) and their impact on autophagy pathways.
- Examination of genetic tools (siRNA, shRNA) for targeting autophagy regulatory complexes.
Main Results:
- Nanoparticles can deliver autophagy regulators and chemotherapeutics, leading to enhanced anti-tumor effects.
- Specific nanostructures like gold and zinc oxide nanoparticles can induce oxidative stress, promoting apoptosis and autophagy.
- Nanoparticle-modulated autophagy potentiates the efficacy of chemotherapy drugs such as cisplatin and gefitinib.
- Various nanomaterials can influence key autophagy regulators including ATGs, Beclin-1, and LC3-II.
Conclusions:
- Nanoparticles represent a versatile platform for modulating autophagy in cancer treatment.
- Targeting autophagy through nanomaterials can enhance the efficacy of existing chemotherapies and induce cancer cell death.
- Further research into the dual role of nanomaterial-induced autophagy (pro-survival vs. pro-death) is critical for optimizing cancer therapy strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Stabilize Microtubules
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

